Computational Fluid Dynamics Analysis to Determine Shear Stresses and Rates in a Centrifugal Left Ventricular Assist Device

Artificial Organs

Volumn 36, Issue 4, 2012, Pages

  Selgrade, Brian Paul ^a   Truskey, George A ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Centrifugal; Endothelium; Fluid dynamics; Hemodynamics; Left ventricular assist device; Shear; Von Willebrand factor

Indexed keywords

CENTRIFUGATION; COMPUTATIONAL FLUID DYNAMICS; ELASTICITY; GLYCOPROTEINS; IMPELLERS; LEFT VENTRICULAR ASSIST DEVICES; SHEAR DEFORMATION; SHEAR FLOW; SHEAR STRESS;

CENTRIFUGAL; ENDOTHELIUM; FLUID-DYNAMICS; HAEMODYNAMICS; HIGH SHEAR; SHEAR; SHEAR-RATE; VON WILLEBRAND FACTOR; WALL SHEAR STRESS; WALL-SHEAR STRESS;

BIOCOMPATIBILITY;

ARTICLE; BIOCOMPATIBILITY; COMPUTATIONAL FLUID DYNAMICS; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; ENDOTHELIUM; EQUIPMENT DESIGN; FLOW RATE; IMPELLER; LAMINAR FLOW; LEFT VENTRICULAR ASSIST DEVICE; PRIORITY JOURNAL; SHEAR STRESS; SIMULATION; SURGICAL EQUIPMENT; TRANSPORT KINETICS; VELOCITY; VISCOSITY;

EID: 84859571244     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01416.x     Document Type: Article

References (24)

1. Slaughter MS, Rogers JG, Milano CA, etal. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
2. Pagani FD, Miller LW, Russell SD, etal. Extended mechanical circulatory support with a continuous-flow, rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-21.
3. Burgreen GW, Loree HM, Bourque K, etal. Computational fluid dynamics analysis of a Maglev centrifugal left ventricular assist device. Artif Organs 2004;28:874-80.
4. Reininger AJ. VWF attributes-impact on thrombus formation. Thromb Res 2008;122:S9-13.
5. Schneider SW, Nuschele S, Wixforth A, etal. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A 2007;104:7899-903.
6. Tsai H, Sussman II, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 1994;83:2171-9.
7. Siedlecki CA, Lestini BJ, Kottke-Marchant K, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996;8:2939-50.
8. Zhang X, Halvorsen K, Zhang C, Wong WP, Springer TA. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science 2009;324:1330-3.
9. Shim K, Anderson PJ, Tuley EA, Wiswall E, Sadler JE. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood 2008;15:651-5.
10. Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science 2009;325:1330-4. Supporting online material.
11. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 2009;53:2162-7.
12. Geisen U, Heilmann H, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008;33:679-84.
13. Steinlechner B, Dworschak M, Birkenberg B, etal. Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg 2009;87:131-8.
14. Crow S, John R, Boyle A, etal. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009;137:208-15.
15. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005;24:105-9.
16. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008;86:1227-35.
17. Vincentelli A, Susen S, Le Tourneau T, etal. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-9.
18. Achneck HE, Jamiolkowski RM, Jantzen AE, etal. The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells. Biomaterials 2011;32:10-8.
19. Tock CL, Bosley JP, Parnis SM, etal. A genetically engineered, nonthrombogenic cellular lining for LVADs: in vitro preconditioning. ASAIO J 1999;39:172-7.
20. Bourque K, Gernes DB, Loree HM, etal. HeartMate III: pump design for a centrifugal LVAD with a magnetically levitated rotor. ASAIO J 2001;47:401-5.
21. Bourque K, Gernes DB, Loree HM, etal. Incorporation of electronics within a compact, fully implanted left ventricular assist device. Artif Organs 2002;26:939-42.
22. Wu J, Paden BE, Borovetz HS, Antaki JF. Computational fluid dynamics analysis of blade tip clearances on hemodynamic performance and blood damage in a centrifugal left ventricular assist device. Artif Organs 2009;34:402-11.
23. Ansys, Inc. ANSYS FLUENT 12.0 Theory Guide. Canonsburg, PA: Ansys, Inc., 2009.
24. Curtas AR, Wood HG, Allaire PE, McDaniel JC, Day SW, Olsen DB. Computational fluid dynamics modeling of impeller designs for the HeartQuest left ventricular assist device. ASAIO J 2002;48:552-62.